178 related articles for article (PubMed ID: 38376353)
1. Bisbenzimide compounds inhibit the replication of prototype and pandemic potential poxviruses.
Samolej J; Mendonca DC; Upfold N; McElwee M; Landsberger M; Yakimovich A; Patel AH; Strang BL; Mercer J
Microbiol Spectr; 2024 Apr; 12(4):e0407223. PubMed ID: 38376353
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide Derivatives.
Yakimovich A; Huttunen M; Zehnder B; Coulter LJ; Gould V; Schneider C; Kopf M; McInnes CJ; Greber UF; Mercer J
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659488
[TBL] [Abstract][Full Text] [Related]
3. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1.
Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C
Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts.
Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
Antiviral Res; 2023 Aug; 216():105651. PubMed ID: 37270160
[TBL] [Abstract][Full Text] [Related]
5. Virulent Poxviruses Inhibit DNA Sensing by Preventing STING Activation.
Georgana I; Sumner RP; Towers GJ; Maluquer de Motes C
J Virol; 2018 May; 92(10):. PubMed ID: 29491158
[TBL] [Abstract][Full Text] [Related]
6. Cardiac glycosides inhibit early and late vaccinia virus protein expression.
Samolej J; White IJ; Strang BL; Mercer J
J Gen Virol; 2024 Mar; 105(3):. PubMed ID: 38546099
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activities of two nucleos(t)ide analogs against vaccinia and mpox viruses in primary human fibroblasts.
Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
bioRxiv; 2023 Mar; ():. PubMed ID: 36993701
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Poxvirus Replication by Resveratrol.
Cao S; Realegeno S; Pant A; Satheshkumar PS; Yang Z
Front Microbiol; 2017; 8():2196. PubMed ID: 29204136
[TBL] [Abstract][Full Text] [Related]
9. Identification of Vaccinia Virus Inhibitors and Cellular Functions Necessary for Efficient Viral Replication by Screening Bioactives and FDA-Approved Drugs.
Peng C; Zhou Y; Cao S; Pant A; Campos Guerrero ML; McDonald P; Roy A; Yang Z
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32708182
[TBL] [Abstract][Full Text] [Related]
10. Identification of
Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus requires glutamine but not glucose for efficient replication.
Fontaine KA; Camarda R; Lagunoff M
J Virol; 2014 Apr; 88(8):4366-74. PubMed ID: 24501408
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
J Virol; 2019 May; 93(10):. PubMed ID: 30814284
[TBL] [Abstract][Full Text] [Related]
13. Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances.
Wang Y
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632084
[TBL] [Abstract][Full Text] [Related]
14. Asparagine Is a Critical Limiting Metabolite for Vaccinia Virus Protein Synthesis during Glutamine Deprivation.
Pant A; Cao S; Yang Z
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996100
[TBL] [Abstract][Full Text] [Related]
15. Acrylamide inhibits vaccinia virus through vimentin-independent anti-viral granule formation.
Wood JJ; White IJ; Samolej J; Mercer J
Cell Microbiol; 2021 Aug; 23(8):e13334. PubMed ID: 33792166
[TBL] [Abstract][Full Text] [Related]
16. Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.
Adamo S; Gao Y; Sekine T; Mily A; Wu J; Storgärd E; Westergren V; Filén F; Treutiger CJ; Sandberg JK; Sällberg M; Bergman P; Llewellyn-Lacey S; Ljunggren HG; Price DA; Ekström AM; Sette A; Grifoni A; Buggert M
Cell Host Microbe; 2023 Jun; 31(6):928-936.e4. PubMed ID: 37236191
[TBL] [Abstract][Full Text] [Related]
17. YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.
Hesser CR; Walsh D
J Virol; 2023 Mar; 97(3):e0175822. PubMed ID: 36916936
[TBL] [Abstract][Full Text] [Related]
18. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
De Clercq E
Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
[TBL] [Abstract][Full Text] [Related]
20. Neutralization Determinants on Poxviruses.
Riccardo V; Pablo GC
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
